Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
Completed · Not applicable
Conditions studied: Pelvic Organ Prolapse, Urinary Tract Infections, Urinary Retention
In brief
Objectives The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a randomized controlled trial comparing the immediate removal of indwelling urethral catheter, after minimally invasive sacrocolpopexy, to the present standard catheter removal on post operative day one. Evidence based catheter management will be helpful to both providers and patients in post-operative decision making. Specific Aims Aim 1: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy results in shorter hospital stay than removal on postoperative day 1. Aim 2: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy confers no increased risk of re-catheterization. Aim 3: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy decreases the occurrence of urinary tract infection. Design A randomized controlled trial comparing the standard overnight indwelling urethral catheterization with removal of catheter immediately post surgery after minimally invasive sacrocolpopexy, at Oregon Health \& Science University. Outcome measures Primary outcome measures are hospital stay in hours after completion of surgery and need for re-catheterization. Hospital stay will be counted from the time the patient leaves the operating room to the time she leaves the hospital. To avoid confounding, investigators are only including the first / morning case of the day. For re-catheterization, investigators will evaluate if patient was able to void after completion of surgery. Investigators will compare the post voiding residuals, the need for re-catheterizations and the numbers of patients going home with an indwelling catheter between the two groups. Investigators will also compare the number of urinary tract infections, as documented by urine culture and subsequent treatment, between the two groups. Study Subjects Study subjects will be women undergoing minimally invasive sacrocolpopexy. Women will be invited to participate in the study during their preoperative visit. If they agree to participation, this will be noted in their chart. Randomization to group will occur immediately following surgery.
Key facts
- Study ID
- NCT02189291
- Run by
- Oregon Health and Science University
- People needed
- 72
- Starts
- 2014-07-01
- Expected to finish
- 2018-12-31
- Last updated by the study team
- 2019-03-15
Who can join
Age: 21 and older, up to 85. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women undergoing minimally invasive sacrocolpopexy
- Sacrocolpopexy with or without concomitant procedures
- Patients having the first start surgery of the day to standardize hospital time.
You may not qualify if…
- Elevated post void residual (PVR)
- Mobility problems
- Neurological conditions
- Intra-operative cystotomy or urinary tract injury
Where it is running
- St John Hospital & Medical Center — Detroit, Michigan, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Legacy Good Samaritan Medical Center — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.